06660.HK
AIM Vaccine Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 1.87
+1.63%Margins
Gross margin
68.8%
EBITDA margin
-6.3%
EBIT margin
-17.8%
Net margin
-41.4%
FCF margin
-5.3%
-35.5%
Return on equity
-14.8%
Return on assets
-9.1%
Return on invested capital
0.35x
Asset turnover
HKD 251.4M
Cash from operations
HKD 0.18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026